On Wednesday, OpenAI announced ChatGPT Health, a dedicated section of the AI chatbot designed for “health and wellness ...
There’s a well-worn pattern in the development of AI chatbots. Researchers discover a vulnerability and exploit it to do ...
The traffic decline isn't a death sentence for AI coding tools, but it is a signal, and it's worth understanding what's ...
This is the second part of our feature examining how retail FX brokers moved beyond platform sameness over the past decade.
WELT, the Samsung spin-off digital‑pharmaceutical company behind the KFDA‑approved and CE‑certified insomnia Digital Therapeutics ‘SleepQ’, announced today that it has been named a CES 2026 Innovation ...
Florida homes are embracing bold geometric patterns, blending Art Deco roots, coastal influences, and modern design for ...
The US government is launching an early career hiring and talent development program to bring more technology and artificial intelligence employees to the public sector, as part of the Trump ...
If you’re one of the 28 percent of Americans who’ve shared an intimate relationship with an AI chatbot, we might have some bad news. Freshly reported testimony from the Data Worker’s Inquiry — an ...
Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...
In 2026, Novo Nordisk’s patent on semaglutide will expire in several countries, including India and China. Generic-drug makers are poised to flood these markets with inexpensive products. Industry ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results